1. Home
  2. News
  3. Mayne Pharma Group Ltd.
  4. 2023 Full Year Results Investor Presentation
More Mayne Pharma Group Ltd. news
Mayne Pharma Group Ltd.ASX: MYX

2023 Full Year Results Investor Presentation

Aug 30, 2023 at 11:28 PM EDT · Issued by Mayne Pharma Group Ltd.

Filed with ASX · Aug 30, 2023 at 11:28 PM EDT · 26 pages · English

On 6ix: 6ix.com/news/2023-full-year-results-investor-presentation-3

Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26↗

Mayne Pharma Group Ltd. on 6ix

In the deck

  • Mayne Pharma Group — FY2023 Earnings Presentation26 slidesAug 31, 2023

Story so far

  • 2023 Half Year Investor PresentationFeb 28, 2023
  • 2022 Full Year Investor PresentationAug 26, 2022
  • 2022 Half Year Investor PresentationFeb 25, 2022

Earlier from Mayne Pharma

  • 2023 Full Year Results Media ReleaseAug 30, 2023
  • Preliminary Final ReportAug 30, 2023
  • MYX provides investor update & announces on market buybackMay 9, 2023
  • Mayne Pharma May 2023 market update presentationMay 9, 2023
  • MYX completes sale of US retail generics business for US$90mApr 10, 2023

Later from Mayne Pharma

  • Mayne Pharma provides update on 1Q FY24 trading and outlookOct 17, 2023
  • Mayne Pharma provides update on first quarter 2024 trading and outlookOct 19, 2023
  • Issuance of additional US Patent for NEXTSTELLISNov 5, 2023
  • Mayne Pharma to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceDec 29, 2023
  • 2024 Half Year Investor PresentationFeb 25, 2024
All Mayne Pharma news releases↗

Follow Mayne Pharma into a list and get an email when it puts out news.

Follow Mayne Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer